Novartis Ag (NVS) Total Current Liabilities (2009 - 2025)

Novartis Ag (NVS) has 12 years of Total Current Liabilities data on file, last reported at $27.3 billion in Q4 2025.

• Quarterly Total Current Liabilities fell 4.93% year-over-year to $27.3 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $27.3 billion (down 4.93% YoY) and the FY2025 annual result came in at $27.3 billion, down 4.93% from the prior year.
• Total Current Liabilities retreated to $27.3 billion in Q4 2025 per NVS's latest filing, from $31.7 billion in the prior quarter.
• The five-year high for Total Current Liabilities was $31.9 billion in Q2 2023, with the low at $25.2 billion in Q2 2021.
• Average Total Current Liabilities over 5 years is $28.5 billion, with a median of $28.2 billion recorded in 2022.
• Year-over-year, Total Current Liabilities gained 15.42% in 2023 and decreased 13.47% in 2024.
• Novartis Ag's Total Current Liabilities stood at $30.2 billion in 2021, then retreated by 5.14% to $28.7 billion in 2022, then fell by 7.91% to $26.4 billion in 2023, then rose by 8.72% to $28.7 billion in 2024, then decreased by 4.93% to $27.3 billion in 2025.
• Business Quant data shows NVS's Total Current Liabilities at $27.3 billion in Q4 2025, $31.7 billion in Q2 2025, and $28.7 billion in Q4 2024.